depression treatment

WALTHAM, Mass., May 12, 2026 Definium Therapeutics announced that the first patient has been dosed in the pivotal ASCEND...

BURLINGTON, Mass. and JERUSALEM, March 31, 2026 BrainsWay Ltd. announced that the U.S. Food and Drug Administration (FDA) has...

OSAKA, Japan, March 19, 2026 Shionogi & Co., Ltd. has officially announced the commercial launch of ZURZUVAE® (zuranolone) 30...